Figure 6.
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin I in Patients With and Those Without Cancer
Overall efficacy in patients without cancer was 77.2% and in patients with cancer was 63.1% (P < 0.001). Abbreviations as in Figure 5.